Publications
2,109
Citations
186,983
Est. group size
~6
Recurring co-author estimate
Active years
60
Publishing since 1967
Typically publishes in teams of ~13 · 6% small-team papers (≤3 authors) · across 122 venues
- HELIOS-B: 12-Month Results From The Open-Label Extension Period Of Vutrisiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy
Journal of Cardiac Failure · 2026
- Spironolactone, Early Acute eGFR Changes, and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT Americas
European Journal of Heart Failure · 2026
- Consistent efficacy of vutrisiran across sexes in transthyretin cardiac amyloidosis: evidence from the HELIOS-B trial
European Journal of Heart Failure · 2026
- Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
New England Journal of Medicine · 2025
- High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults
New England Journal of Medicine · 2025
- SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria
JAMA · 2025
- Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis
The Lancet · 2025
- Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration
JAMA Cardiology · 2025
- RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults
New England Journal of Medicine · 2025
- Transthyretin amyloid cardiomyopathy: from cause to novel treatments
European Heart Journal · 2025
- Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment
European Heart Journal · 2025
- Heart Failure With Improved Ejection Fraction
Journal of the American College of Cardiology · 2025
- Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
The Lancet Diabetes & Endocrinology · 2025
- Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin
JACC Heart Failure · 2025
- Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial
Nature Medicine · 2025
- Journal of the American College of Cardiology×212
- Circulation×206
- European Journal of Heart Failure×164
- European Heart Journal×139
- JACC Heart Failure×124
- Chris Watson
Medicine · University of Michigan
- Garrie J. Haas
Medicine · The Ohio State University
- William T. Abraham
Medicine · The Ohio State University
- Khadijah Breathett
Medicine · Indiana University
- John M. Nicklas
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile